These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 14976608)

  • 1. Fosmidomycin-clindamycin for Plasmodium falciparum Infections in African children.
    Borrmann S; Adegnika AA; Matsiegui PB; Issifou S; Schindler A; Mawili-Mboumba DP; Baranek T; Wiesner J; Jomaa H; Kremsner PG
    J Infect Dis; 2004 Mar; 189(5):901-8. PubMed ID: 14976608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fosmidomycin-clindamycin for the treatment of Plasmodium falciparum malaria.
    Borrmann S; Issifou S; Esser G; Adegnika AA; Ramharter M; Matsiegui PB; Oyakhirome S; Mawili-Mboumba DP; Missinou MA; Kun JF; Jomaa H; Kremsner PG
    J Infect Dis; 2004 Nov; 190(9):1534-40. PubMed ID: 15478056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fosmidomycin plus clindamycin for treatment of pediatric patients aged 1 to 14 years with Plasmodium falciparum malaria.
    Borrmann S; Lundgren I; Oyakhirome S; Impouma B; Matsiegui PB; Adegnika AA; Issifou S; Kun JF; Hutchinson D; Wiesner J; Jomaa H; Kremsner PG
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2713-8. PubMed ID: 16870763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-course regimens of artesunate-fosmidomycin in treatment of uncomplicated Plasmodium falciparum malaria.
    Borrmann S; Adegnika AA; Moussavou F; Oyakhirome S; Esser G; Matsiegui PB; Ramharter M; Lundgren I; Kombila M; Issifou S; Hutchinson D; Wiesner J; Jomaa H; Kremsner PG
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3749-54. PubMed ID: 16127049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the pharmacokinetics and dynamics of two combination regimens of fosmidomycin-clindamycin in patients with acute uncomplicated falciparum malaria.
    Ruangweerayut R; Looareesuwan S; Hutchinson D; Chauemung A; Banmairuroi V; Na-Bangchang K
    Malar J; 2008 Oct; 7():225. PubMed ID: 18973702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artesunate-clindamycin versus quinine-clindamycin in the treatment of Plasmodium falciparum malaria: a randomized controlled trial.
    Ramharter M; Oyakhirome S; Klein Klouwenberg P; Adégnika AA; Agnandji ST; Missinou MA; Matsiégui PB; Mordmüller B; Borrmann S; Kun JF; Lell B; Krishna S; Graninger W; Issifou S; Kremsner PG
    Clin Infect Dis; 2005 Jun; 40(12):1777-84. PubMed ID: 15909266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of fosmidomycin monotherapy and combination therapy with clindamycin in the treatment of multidrug resistant falciparum malaria.
    Na-Bangchang K; Ruengweerayut R; Karbwang J; Chauemung A; Hutchinson D
    Malar J; 2007 May; 6():70. PubMed ID: 17531088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in Thailand.
    Noedl H; Krudsood S; Chalermratana K; Silachamroon U; Leowattana W; Tangpukdee N; Looareesuwan S; Miller RS; Fukuda M; Jongsakul K; Sriwichai S; Rowan J; Bhattacharyya H; Ohrt C; Knirsch C
    Clin Infect Dis; 2006 Nov; 43(10):1264-71. PubMed ID: 17051490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.
    Sowunmi A; Fehintola FA; Adedeji AA; Gbotosho GO; Tambo E; Fateye BA; Happi TC; Oduola AM
    Trop Med Int Health; 2005 Nov; 10(11):1161-70. PubMed ID: 16262741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fosmidomycin for the treatment of malaria.
    Wiesner J; Borrmann S; Jomaa H
    Parasitol Res; 2003 Jun; 90 Suppl 2():S71-6. PubMed ID: 12937969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fosmidomycin for malaria.
    Missinou MA; Borrmann S; Schindler A; Issifou S; Adegnika AA; Matsiegui PB; Binder R; Lell B; Wiesner J; Baranek T; Jomaa H; Kremsner PG
    Lancet; 2002 Dec; 360(9349):1941-2. PubMed ID: 12493263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed parasite elimination in human infections treated with clindamycin parallels 'delayed death' of Plasmodium falciparum in vitro.
    Burkhardt D; Wiesner J; Stoesser N; Ramharter M; Uhlemann AC; Issifou S; Jomaa H; Krishna S; Kremsner PG; Borrmann S
    Int J Parasitol; 2007 Jun; 37(7):777-85. PubMed ID: 17280676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inadequate efficacy of a new formulation of fosmidomycin-clindamycin combination in Mozambican children less than three years old with uncomplicated Plasmodium falciparum malaria.
    Lanaspa M; Moraleda C; Machevo S; González R; Serrano B; Macete E; Cisteró P; Mayor A; Hutchinson D; Kremsner PG; Alonso P; Menéndez C; Bassat Q
    Antimicrob Agents Chemother; 2012 Jun; 56(6):2923-8. PubMed ID: 22430959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-Genome Sequencing to Evaluate the Resistance Landscape Following Antimalarial Treatment Failure With Fosmidomycin-Clindamycin.
    Guggisberg AM; Sundararaman SA; Lanaspa M; Moraleda C; González R; Mayor A; Cisteró P; Hutchinson D; Kremsner PG; Hahn BH; Bassat Q; Odom AR
    J Infect Dis; 2016 Oct; 214(7):1085-91. PubMed ID: 27443612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced efficacy of amodiaquine and chlorpheniramine combination over amodiaquine alone in the treatment of acute uncomplicated Plasmodium falciparum malaria in children.
    Falade CO; Michael SO; Oduola AM
    Med Princ Pract; 2008; 17(3):197-201. PubMed ID: 18408387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Fosmidomycin-Piperaquine as Nonartemisinin-Based Combination Therapy for Uncomplicated Falciparum Malaria: A Single-Arm, Age De-escalation Proof-of-Concept Study in Gabon.
    Mombo-Ngoma G; Remppis J; Sievers M; Zoleko Manego R; Endamne L; Kabwende L; Veletzky L; Nguyen TT; Groger M; Lötsch F; Mischlinger J; Flohr L; Kim J; Cattaneo C; Hutchinson D; Duparc S; Moehrle J; Velavan TP; Lell B; Ramharter M; Adegnika AA; Mordmüller B; Kremsner PG
    Clin Infect Dis; 2018 Jun; 66(12):1823-1830. PubMed ID: 29293893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial of amodiaquine and artesunate alone and in combination for the treatment of uncomplicated falciparum malaria in children from Burkina Faso.
    Barennes H; Nagot N; Valea I; Koussoubé-Balima T; Ouedraogo A; Sanou T; Yé S
    Trop Med Int Health; 2004 Apr; 9(4):438-44. PubMed ID: 15078261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fosmidomycin as an antimalarial drug: a meta-analysis of clinical trials.
    Fernandes JF; Lell B; Agnandji ST; Obiang RM; Bassat Q; Kremsner PG; Mordmüller B; Grobusch MP
    Future Microbiol; 2015; 10(8):1375-90. PubMed ID: 26228767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fosmidomycin, a novel chemotherapeutic agent for malaria.
    Lell B; Ruangweerayut R; Wiesner J; Missinou MA; Schindler A; Baranek T; Hintz M; Hutchinson D; Jomaa H; Kremsner PG
    Antimicrob Agents Chemother; 2003 Feb; 47(2):735-8. PubMed ID: 12543685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of peroxisome proliferator-activated receptor gamma agonists as adjunctive treatment for Plasmodium falciparum malaria: a randomized, double-blind, placebo-controlled trial.
    Boggild AK; Krudsood S; Patel SN; Serghides L; Tangpukdee N; Katz K; Wilairatana P; Liles WC; Looareesuwan S; Kain KC
    Clin Infect Dis; 2009 Sep; 49(6):841-9. PubMed ID: 19673614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.